Salipro Biotech Receives European Patent for Antigen production
Approvals in this patent family both in Europe as well as in the US further strengthen Salipro Biotech’s proprietary platform technologies to enable drug discovery programs for therapeutic antibodies against challenging drug targets.Stockholm, Sweden, February 8, 2022 – Swedish biotech company Salipro Biotech AB today announced that the European Patent Office has granted a further European Patent to the company, No. EP 3 043 814 B1 entitled “Antigen and method for production thereof”, following the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2.